newsfilter
← Latest News
Business Wire·

Forte Biosciences to Host R&D Day December 3, 2024

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will host an R&D Day on December 3,